Know Labs, Inc. announced it has filed an appeal against the NYSE American’s commencement of proceedings to delist the company from its exchange. This action follows the NYSE American's determination that Know Labs was no longer suitable for listing due to its bid price falling below $0.10.
The company is actively pursuing curative actions aimed at regaining compliance with listing standards while its appeal is under review by the Listings Qualifications Panel. This appeal represents an effort to reverse the delisting decision and restore trading on the NYSE American.
Know Labs' common stock was suspended from trading on the NYSE American and is currently quoted and traded on the OTC Markets under the symbol "KNWN." The appeal process is a critical step for the company in its efforts to maintain its exchange listing.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.